BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 22122915)

  • 1. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
    Sanovic R; Verwanger T; Hartl A; Krammer B
    Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY; Bay BH; Olivo M
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B; Zupkó I; de Witte PA
    Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
    Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
    Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY; Olivo M; Tan BK; Bay BH
    Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
    Boiy A; Roelandts R; van den Oord J; de Witte PA
    Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photosensitizer nanoparticles photodynamic therapy on LOVO human colon cancer xenografts in athymic mice].
    Qing SH; Li LY; Sheng XH; Ba MC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):530-3. PubMed ID: 17143803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
    Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
    Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
    Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
    Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
    Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
    Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing.
    Cavarga I; Brezáni P; Fedorocko P; Miskovský P; Bobrov N; Longauer F; Rybárova S; Mirossay L; Stubna J
    Phytomedicine; 2005 Sep; 12(9):680-3. PubMed ID: 16194057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
    Ali SM; Olivo M
    Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA; Huygens A; De Witte PA
    Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.